Aurobindo Pharma consolidated net profit rises 61.05% in the June 2024 quarter

Net profit of Aurobindo Pharma rose 61.05% to Rs 919.22 crore in the quarter ended June 2024 as against Rs 570.75 crore during the previous quarter ended June 2023. Sales rose 9.82% to Rs 7457.65 crore in the quarter ended June 2024 as against Rs 6790.64 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	7457.65	6790.64	10
OPM %	21.70	16.91	-
PBDT	1728.07	1208.34	43
PBT	1323.89	881.78	50
NP	919.22	570.75	61